Divergent WNT signaling and drug sensitivity profiles within hepatoblastoma tumors and organoids

Abstract Hepatoblastoma, the most prevalent pediatric liver cancer, almost always carries a WNT-activating CTNNB1 mutation, yet exhibits notable molecular heterogeneity. To characterize this heterogeneity and identify novel targeted therapies, we perform comprehensive analysis of hepatoblastomas and...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Thomas A. Kluiver, Yuyan Lu, Stephanie A. Schubert, Lianne J. Kraaier, Femke Ringnalda, Philip Lijnzaad, Jeff DeMartino, Wouter L. Megchelenbrink, Vicky Amo-Addae, Selma Eising, Flavia W. de Faria, Daniel Münter, Marc van de Wetering, Kornelius Kerl, Evelien Duiker, Marius C. van den Heuvel, Vincent E. de Meijer, Ruben H. de Kleine, Jan J. Molenaar, Thanasis Margaritis, Hendrik G. Stunnenberg, Ronald R. de Krijger, József Zsiros, Hans Clevers, Weng Chuan Peng
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Nature Portfolio 2024-11-01
Serie:	Nature Communications
Accesso online:	https://doi.org/10.1038/s41467-024-52757-w
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!